Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of metformin HCl in combination with colesevelam HCl, compared to metformin HCl alone, as initial therapy in drug naive subjects with type 2 diabetes mellitus, and the effects of colesevelam HCl on the lipid profile in subjects with pre diabetes.

Next Previous
Trial Profile

Effects of metformin HCl in combination with colesevelam HCl, compared to metformin HCl alone, as initial therapy in drug naive subjects with type 2 diabetes mellitus, and the effects of colesevelam HCl on the lipid profile in subjects with pre diabetes.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 20 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc

    • Most Recent Events

    • 26 Jun 2010 Results were presented at the 70th Scientific Sessions of the American Diabetes Association, according to a Daiichi Sankyo media release.
    • 25 Jun 2010 Results of the type 2 diabetes mellitus cohort have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA 2010).
    • 07 Aug 2009 Actual end date (1 Jul 2009) added as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top